EPISODE · Aug 26, 2026 · 8 MIN
Sell, Defer, and Leave a Legacy: How CRTs Change the M&A Game
from HOLDco · host Hold.co
For founders who've spent decades building a company, the tax bill that follows a successful exit can feel like a betrayal. Charitable Remainder Trusts — a sophisticated but underused planning tool — offer a way to reframe the entire liquidity event, turning a single taxable windfall into a structure that delivers deferred tax, steady income, and philanthropic impact simultaneously. This episode of HoldCo walks through the mechanics, the tradeoffs, and the deal-timing rules that determine whether a CRT works or falls apart. It's based on the in-depth M&A analysis of CRTs for business sellers published at Mergers & Acquisitions. Here's what the episode covers: How CRTs work at a structural level — why a tax-exempt trust executing the sale, rather than the founder directly, changes the entire capital gains calculus CRUTs vs. CRATs — the difference between a variable annual payout tied to portfolio performance and a fixed annuity-style income stream, and which tends to suit M&A sellers better The three stacking advantages — capital gains deferral, lifetime income conversion, and an immediate charitable deduction, all triggered by a single coordinated move at closing The critical timing rule — why shares must be transferred into the trust before any binding sale agreement is signed, and how experienced deal counsel can build that window into the transaction structure S-corp and LLC considerations — special shareholder eligibility rules that require early planning, and how entity-level debt complicates contributed interests Wealth-replacement strategies for heirs — how an irrevocable life insurance trust funded from CRT income can preserve or even enhance what passes to the next generation, even though the trust remainder goes to charity The episode also addresses two common objections head-on: the fear of losing control over assets once they're inside an irrevocable trust, and the assumption that CRTs are only viable for nine-figure exits. On both counts, the reality is more nuanced — and more accessible — than most founders expect. For more on deal structure and the financial metrics that drive M&A outcomes, check out the earlier HoldCo episode Why EBITDA Lies: PE's Favorite Financial Fairy Tale. Mergers & Acquisitions VDR
Embed this episode
What this episode covers
Charitable Remainder Trusts can turn a business sale into a multi-dimensional win — deferring capital gains, generating lifetime income, and funding a lasting legacy. This episode breaks down how CRTs work and what founders must get right before the deal closes.
NOW PLAYING
Sell, Defer, and Leave a Legacy: How CRTs Change the M&A Game
No transcript for this episode yet
Similar Episodes
No similar episodes found.